Cargando…

Correction: STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

Detalles Bibliográficos
Autores principales:	Toth, Karoly, Lee, Sang R., Ying, Baoling, Spencer, Jacqueline F., Tollefson, Ann E., Sagartz, John E., Kong, Il-Keun, Wang, Zhongde, Wold, William S. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706453/ https://www.ncbi.nlm.nih.gov/pubmed/26745633 http://dx.doi.org/10.1371/journal.ppat.1005392

Ejemplares similares

STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control
por: Toth, Karoly, et al.
Publicado: (2015)

Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters
por: Toth, Karoly, et al.
Publicado: (2015)

The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
por: Young, Brittany A., et al.
Publicado: (2013)

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013)

Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients
por: Li, Rong, et al.
Publicado: (2020)

Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters
por: Ying, Baoling, et al.
Publicado: (2015)

Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9
por: Miao, Jinxin, et al.
Publicado: (2018)

HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model
por: Toth, Karoly, et al.
Publicado: (2017)

Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters
por: Schaar, Katrin, et al.
Publicado: (2017)

Cycles of Transient High-Dose Cyclophosphamide Administration and Oncolytic Adenovirus Vector Intratumoral Injection for Long Term Tumor Suppression in Syrian Hamsters
por: Dhar, Debanjan, et al.
Publicado: (2014)

Golden Syrian Hamster Models for Cancer Research
por: Wang, Zhongde, et al.
Publicado: (2022)

An immunosuppressed Syrian golden hamster model for SARS-CoV infection
por: Schaecher, Scott R., et al.
Publicado: (2008)

Pathogenesis of Rift Valley Fever Virus Aerosol Infection in STAT2 Knockout Hamsters
por: Hickerson, Brady T., et al.
Publicado: (2018)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Efficient Gene Targeting in Golden Syrian Hamsters by the CRISPR/Cas9 System
por: Fan, Zhiqiang, et al.
Publicado: (2014)

Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster
por: Radke, Jay R., et al.
Publicado: (2020)

LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942)

Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
por: Kim, Julius Woongki, et al.
Publicado: (2016)

Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system
por: Miao, Jinxin, et al.
Publicado: (2022)

Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

The Experimental Use of Syrian Hamsters
por: Valentine, Helen, et al.
Publicado: (2012)

Corrigendum: Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

A novel cancer syndrome caused by KCNQ1-deficiency in the golden Syrian hamster
por: Li, Rong, et al.
Publicado: (2018)

Aflatoxin induced lesions in Syrian hamsters.
por: Herrold, K. M.
Publicado: (1969)

Detection of natural cytotoxicity in Syrian hamsters.
por: Rees, R. C., et al.
Publicado: (1980)

Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014)

Evaluation of apoptogenic adenovirus type 5 oncolytic vectors in a Syrian hamster head and neck cancer model
por: Vijayalingam, S., et al.
Publicado: (2014)

Human Polyclonal Antibodies Produced from Transchromosomal Bovine Provides Prophylactic and Therapeutic Protections Against Zika Virus Infection in STAT2 KO Syrian Hamsters
por: Siddharthan, Venkatraman, et al.
Publicado: (2019)

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2013)

Selenite Downregulates STAT3 Expression and Provokes Lymphocytosis in the Liver of Chronically Exposed Syrian Golden Hamsters
por: Camacho-Moll, María Elena, et al.
Publicado: (2021)

Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014)

New Semi-dominant Mutation in the Syrian Hamster
por: FESTING, M. F. W., et al.
Publicado: (1972)

Influenza Viruses Suitable for Studies in Syrian Hamsters
por: Fan, Shufang, et al.
Publicado: (2022)

Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
por: Lake, B G, et al.
Publicado: (1993)

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters
por: Brocato, Rebecca L., et al.
Publicado: (2020)

Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
por: Geisler, Anja, et al.
Publicado: (2023)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2
por: Yang, Shiu-Ju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qjf6cetis3a2mqkiathtg6iq8g